6
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Acute Administration of Individual Optimal Dose of Physostigmine Fails to Improve Mnesic Performances in Alzheimers Presenile Dementia

, , &
Pages 143-147 | Received 02 Aug 1982, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

D. D. Cardenas, A. McLean, L. Farrell-roberts, L. Baker, M. Brooke & J. Haselkorn. (1994) Oral physostigmine and impaired memory in adults with brain injury. Brain Injury 8:7, pages 579-587.
Read now
Alvin McLean, Karen M. Stanton, Diana D. Cardenas & Donna B. Bergerud. (1987) Memory training combined with the use of oral physostigmine. Brain Injury 1:2, pages 145-159.
Read now

Articles from other publishers (13)

Sergey Shityakov, Ekaterina V. Skorb, Carola Y. Förster & Thomas Dandekar. (2021) Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease. Frontiers in Chemistry 9.
Crossref
João M JMC Coelho Filho & Jacqueline Birks. (2001) Physostigmine for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews.
Crossref
Jair C. Soares & Samuel Gershon. (1994) Advances in the pharmacotherapy of Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience 244:5, pages 261-271.
Crossref
Anthony Wetherell. (1992) Effects of physostigmine on stimulus encoding in a memory-scanning task. Psychopharmacology 109:1-2, pages 198-202.
Crossref
Nobuya Matsuoka, Noriaki Maeda, Yoshitaka Ohkubo & Isamu Yamaguchi. (1991) Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats. Brain Research 559:2, pages 233-240.
Crossref
Pow F. Kwo-On-Yuen, Ronald Mandel, Andrew D. Chen & Leon J. Thal. (1990) Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats. Experimental Neurology 108:3, pages 221-228.
Crossref
. 1988. Memory Disorders in Clinical Practice. Memory Disorders in Clinical Practice 219 268 .
Clifford B. Saper. 1988. Handbook of Psychopharmacology. Handbook of Psychopharmacology 131 156 .
L. Gustafson, L. Edvinsson, N. Dahlgren, B. Hagberg, J. Risberg, I. Rosén & H. Fernö. (1987) Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychopharmacology 93:1, pages 31-35.
Crossref
Dee S. Parsons, Andrea Peagler, T.Steven Barlow & Lindy E. Harrell. (1987) Failure of chronic physostigmine to ameliorate working memory deficits after medial septal lesions. Experimental Neurology 96:2, pages 456-461.
Crossref
Aman U. KhanAman U. Khan. 1986. Clinical Disorders of Memory. Clinical Disorders of Memory 105 119 .
Aman U. KhanAman U. Khan. 1986. Clinical Disorders of Memory. Clinical Disorders of Memory 67 87 .
Aman U. KhanAman U. Khan. 1986. Clinical Disorders of Memory. Clinical Disorders of Memory 239 256 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.